The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hawryluk P. Kent since 2016.
This trader's CIK number is 1673991.
At the time of last reporting, Hawryluk P. Kent was the President & CEO of Mbx Biosciences, Inc.. (stock ticker symbol MBX).
Also see all insider trading activities at Mbx Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MBX | 50,000 | $534,500 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GEMP | 25,000 | $236,750 | 0 | $0 | 0 | $0 |
| 2016 | GEMP | 25,000 | $250,000 | 0 | $0 | 0 | $0 |
1. Mbx Biosciences, Inc. (MBX)
2. Neurobo Pharmaceuticals, Inc. (GEMP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-04 | MBX | Buy | 50,000 | 10.69 | 534,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-10 | GEMP | Buy | 25,000 | 9.47 | 236,750 |
| 2016-08-10 | GEMP | Buy | 25,000 | 10.00 | 250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hawryluk P. Kent (President & CEO of Mbx Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.